Weitian Xu

521 total citations
9 papers, 210 citations indexed

About

Weitian Xu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Weitian Xu has authored 9 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cancer Research and 1 paper in Surgery. Recurrent topics in Weitian Xu's work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (3 papers) and Molecular Biology Techniques and Applications (2 papers). Weitian Xu is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (3 papers) and Molecular Biology Techniques and Applications (2 papers). Weitian Xu collaborates with scholars based in China. Weitian Xu's co-authors include Yimin Xiong, Guorong Zheng, Zhi Yan, Yi Cheng, Zhigang Wang, Juan Gao, Fang Chen, Fang Chen, Hualin Xu and Yan Wang and has published in prestigious journals such as PLoS ONE, International Journal of Oncology and Oncology Reports.

In The Last Decade

Weitian Xu

7 papers receiving 209 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weitian Xu China	6	157	130	31	28	26	9	210
Hark K. Kim South Korea	5	141 0.9×	124 1.0×	55 1.8×	41 1.5×	23 0.9×	10	214
Khoon Leong Ng Malaysia	6	156 1.0×	75 0.6×	55 1.8×	41 1.5×	27 1.0×	10	287
Angeliki Pantazi United States	7	129 0.8×	99 0.8×	38 1.2×	32 1.1×	11 0.4×	11	190
Wenfei Xia China	9	207 1.3×	198 1.5×	28 0.9×	21 0.8×	25 1.0×	13	268
Minjun Du China	8	275 1.8×	218 1.7×	25 0.8×	31 1.1×	19 0.7×	18	313
Dongxin Lin China	6	236 1.5×	144 1.1×	33 1.1×	22 0.8×	14 0.5×	9	259
Guozhi Yin China	13	275 1.8×	236 1.8×	58 1.9×	39 1.4×	41 1.6×	19	371
Minghui Ge China	6	111 0.7×	80 0.6×	48 1.5×	30 1.1×	12 0.5×	13	162
Zi-Yang Peng China	9	157 1.0×	93 0.7×	39 1.3×	33 1.2×	16 0.6×	17	196
Guohua Zhang China	6	180 1.1×	166 1.3×	27 0.9×	27 1.0×	27 1.0×	7	230

Countries citing papers authored by Weitian Xu

Since Specialization

Citations

This map shows the geographic impact of Weitian Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weitian Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weitian Xu more than expected).

Fields of papers citing papers by Weitian Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weitian Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weitian Xu. The network helps show where Weitian Xu may publish in the future.

Co-authorship network of co-authors of Weitian Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Weitian Xu. A scholar is included among the top collaborators of Weitian Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weitian Xu. Weitian Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Zhang, Xiaohong, Yali Ren, Lu Huang, et al.. (2024). Regorafenib enhances the efficacy of photodynamic therapy in hepatocellular carcinoma through MAPK signaling pathway suppression. Photodiagnosis and Photodynamic Therapy. 49. 104319–104319.

2.

Shang, Shenglan, et al.. (2023). A 47-Year-Old Man with Hyperphosphatemia Due to Chronic Renal Failure Treated with Lanthanum Carbonate Tablets Presenting Acutely with Partial Large Bowel Obstruction. American Journal of Case Reports. 24. e942113–e942113.

3.

Jin, Lei, et al.. (2018). Efficacy and safety of Bifidobacterium combined with ilaprazole-containning quadruple therapy in rescue eradication of Helicobacter pylori. World Chinese Journal of Digestology. 26(4). 256–256. 1 indexed citations

4.

Zheng, Guorong, Yimin Xiong, Weitian Xu, et al.. (2014). A two-microRNA signature as a potential biomarker for early gastric cancer. Oncology Letters. 7(3). 679–684. 30 indexed citations

5.

Yan, Zhi, Weitian Xu, Yimin Xiong, et al.. (2013). Highly accurate two-gene signature for gastric cancer. Medical Oncology. 30(2). 584–584. 10 indexed citations

6.

Yan, Zhi, Yimin Xiong, Weitian Xu, et al.. (2012). Identification of recurrence-related genes by integrating microRNA and gene expression profiling of gastric cancer. International Journal of Oncology. 41(6). 2166–2174. 18 indexed citations

7.

Gao, Juan, Yongqiang Dong, Bicheng Zhang, et al.. (2012). Notch1 activation contributes to tumor cell growth and proliferation in human hepatocellular carcinoma HepG2 and SMMC7721 cells. International Journal of Oncology. 41(5). 1773–1781. 25 indexed citations

8.

Yan, Zhi, Yimin Xiong, Weitian Xu, et al.. (2012). Identification of hsa-miR-335 as a Prognostic Signature in Gastric Cancer. PLoS ONE. 7(7). e40037–e40037. 87 indexed citations

9.

Yan, Zhi, et al.. (2012). Identification of candidate colon cancer biomarkers by applying a random forest approach on microarray data. Oncology Reports. 28(3). 1036–1042. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact